Senior insider sale
Chief Medical Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$227.0K
12.34K shares
What this filing means
JANKU FILIP plans to sell 12.34K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $227.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/23/2026ACC: 0001950047-26-001676
Officer· Chief Medical Officer
Since Jun 2021
12.34K
Shares to sell
$227.0K
Approx. market value
9.19K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
Employee Stock Purchase Plan
Cash
6/28/2024
3.94KEmployee Stock Purchase Plan
Cash
12/29/2023
1.28KEmployee Stock Purchase Plan
Cash
6/30/2023
2.15KEmployee Stock Purchase Plan
Cash
12/30/2022
1.82KTotal acquired9.19K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/28/2024 | Employee Stock Purchase Plan Cash | 3.94K | — |
12/29/2023 | Employee Stock Purchase Plan Cash | 1.28K | — |
6/30/2023 | Employee Stock Purchase Plan Cash | 2.15K | — |
12/30/2022 | Employee Stock Purchase Plan Cash | 1.82K | — |
| Total | 9.19K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.15K
Market value
$47.9K
1/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.19K
Market value
$179.2K
2/23/2026
Total
Units
12.34K
Value
$227.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/5/2026 | 3.15K | $47.9K | — | Completed |
| Planned — Approximate Date | ||||
2/23/2026 | 9.19K | $179.2K | NASDAQ | Planned |
| Total | 12.34K | $227.0K | ||